Changes in serum albumin levels and neutrophil–lymphocyte ratio in patients with convulsive status epilepticus

International Journal of Neuroscience

Volumn 127, Issue 5, 2017, Pages 417-420

  Özdemir, Hasan H ^a   Akil, Esref ^a   Acar, Abdullah ^a   Tamam, Yusuf ^a   Varol, Sefer ^a   Cevik, Mehmet Ugur ^a   Arikanoglu, Adalet ^a  

^a DICLE UNIVERSITY   (Turkey)

Author keywords

albumin; convulsive status epilepticus; inflammation; neutrophil lymphocyte ratio

Indexed keywords

ALBUMIN; LEVETIRACETAM; PHENYTOIN; VALPROIC ACID; SERUM ALBUMIN;

ADOLESCENT; ADULT; AGED; ALBUMIN BLOOD LEVEL; ARTICLE; CHEMICAL ANALYZER; COMPARATIVE STUDY; COMPLEX PARTIAL SECONDARY GENERALIZED CONVULSIVE STATUS EPILEPTICUS; CONTROLLED STUDY; CONVULSIVE STATUS EPILEPTICUS; EPILEPTIC STATE; FEMALE; GENERALIZED CONVULSIVE STATUS EPILEPTICUS; HEMATOLOGY EQUIPMENT; HUMAN; IDIOPATHIC DISEASE; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; NERVOUS SYSTEM INFLAMMATION; NEUROPATHOLOGY; NEUTROPHIL COUNT; NEUTROPHIL LYMPHOCYTE RATIO; RETROSPECTIVE STUDY; TONIC STATUS EPILEPTICUS; BLOOD; COMPLICATION; FAINTNESS; INFLAMMATION; LYMPHOCYTE; METABOLISM; MIDDLE AGED; NEUTROPHIL; PATHOLOGY; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; INFLAMMATION; LYMPHOCYTE COUNT; LYMPHOCYTES; MALE; MIDDLE AGED; NEUTROPHILS; SERUM ALBUMIN; STATUS EPILEPTICUS; SYNCOPE; YOUNG ADULT;

EID: 84969771901     PISSN: 00207454     EISSN: 15635279     Source Type: Journal    
DOI: 10.1080/00207454.2016.1187606     Document Type: Article

References (20)

1. De Reuck J, Van Maele G. Status epilepticus in stroke patients. Eur Neurol 2009;62(3):171–5.
2. Ravizza T, Gagliardi B, Noe F, et al. Innate and adaptive immunity during epileptogenesis and spontaneous seizures:evidence from experimental models and human temporal lobe epilepsy. Neurobiol Dis 2008;29(1):142--60.
3. Vezzani A, Granata T. Brain inflammation in epilepsy:experimental and clinical evidence. Epilepsia 2005;46:1724–43.
4. Sutter R, Grize L, Fuhr P, et al. Acute-phase proteins and mortality in status epilepticus:a 5-year observational cohort study. Crit Care Med 2013;41(6):1526–33.
5. Akıl E, Bulut A, Kaplan, İ, et al. The increase of carcinoembryonic antigen (CEA), high-sensitivity C-reactive protein, and neutrophil/lymphocyte ratio in Parkinson's disease. Neurol Sci 2015;36(3):423–8.
6. Akıl E, Akıl MA, Varol S, et al. Echocardiographic epicardial fat thickness and neutrophil to lymphocyte ratio are novel inflammatory predictors of cerebral ischemic stroke. J Stroke Cerebrovasc Dis 2014;23(9):2328–34.
7. Fabene PF, Navarro Mora G, Martinello M, et al. A role for leukocyte-endothelial adhesion mechanisms in epilepsy. Nat Med 2008;14(12):1377–83.
8. Janigro D, Iffland, PH, 2nd, Marchi N, et al. A role for inflammation in status epilepticus is revealed by a review of current therapeutic approaches. Epilepsia 2013;54(6):30–2
9. Commission on Classification and Terminology of the International League Against Epilepsy. Proposal for revised clinical and electro-encephalographic classification of epileptic seizures. Epilepsia 1981;22(4):489–501.
10. Vezzani A, Dingledine R, Rossetti AO. Immunity and inflammation in status epilepticus and its sequelae:possibilities for therapeutic application. Expert Rev Neurother 2015;15(9):1081–92.
11. Ravizza T, Gagliardi B, Noé, F, et al. Innate and adaptive immunity during epileptogenesis and spontaneous seizures:evidence from experimental models and human temporal lobe epilepsy. Neurobiol Dis 2008;29:142–60.
12. Oby E, Janigro D. The blood-brain barrier and epilepsy. Epilepsia 2006;47:1761–74.
13. Carter AM, Catto AJ, Mansfield MW, et al. Predictive variables for mortality after acute ischemic stroke. Stroke 2007;38:1873–80.
14. Gillum RF, Makuc DM, :Serum albumin, coronary heart disease, and death. Am Heart J 1992;123:507–13.
15. Li G, Bauer S, Nowak M, et al. Cytokines and epilepsy. Seizure 2011;20:249–56.
16. Johnson EA, Guignet MA, Dao TL, et al. Interleukin-18 expression increases in response to neurovascular damage following soman-induced status epilepticus in rats. J Inflamm (Lond) 2015;12:43.
17. Aras YG, Gungen BD, Kotan D. Neutrophil/lymphocyte ratios in migraine patients and its correlation with aura. Ajans 2015;3(4):162–6.
18. Walsh SR, Cook EJ, Goulder F, et al. Neutrophil-lymphocyte ratio as a prognostic factor in colorectal cancer. J Surg Oncol 2005;91:181–4.
19. Alan S, Tuna S, Türkoğlu EB. The relation of neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and mean platelet volume with the presence and severity of Behçet's syndrome. Kaohsiung J Med Sci 2015;31(12):626–31.
20. Demirci S, Demirci S, Kutluhan S, et al. The clinical significance of the neutrophil-to-lymphocyte ratio in multiple sclerosis. Int J Neurosci 2015 Oct 12:1–7. DOI:10.3109/00207454.2015.1050492